ClearBridge Investments’s Orexigen Therapeutics, Inc. OREX Stock Holding History

ClearBridge Investments’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-19,341	Closed	-$408K	–	1216
2015 Q3	$408K	Hold	19,341	–	–	﹤0.01%	806
2015 Q2	$957K	Sell	19,341 -9,000	-32%	-$538K	﹤0.01%	750
2015 Q1	$2.22M	Buy	28,341 +4,221	+18%	+$262K	﹤0.01%	677
2014 Q4	$1.46M	Hold	24,120	–	–	﹤0.01%	734
2014 Q3	$1.03M	Sell	24,120 -2,380	-9%	-$128K	﹤0.01%	761
2014 Q2	$1.64M	Buy	+26,500	New	+$1.54M	﹤0.01%	689

Other funds holding OREX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments's OREX Position: Q4 2015 in Review

ClearBridge Investments sold out of Orexigen Therapeutics, Inc. (OREX) in Q4 2015, closing a stake of 19,341 shares — an estimated $408K sold.

ClearBridge Investments first reported a position in OREX in Q2 2014 and held it in 6 quarters. The position peaked at $2.22M in Q1 2015. 121 funds tracked by Wall St. Rank hold OREX as of Q4 2015.

ClearBridge Investments reported no remaining Orexigen Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
ClearBridge Investments sold 19,341 Orexigen Therapeutics, Inc. shares in Q4 2015, an estimated $408K.
ClearBridge Investments first reported a position in Orexigen Therapeutics, Inc. in Q2 2014 and held it in 6 quarters.
ClearBridge Investments's Orexigen Therapeutics, Inc. position peaked at $2.22M in Q1 2015.
121 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q4 2015.

Based on ClearBridge Investments's 13F filing for Q4 2015, filed 16 Feb 2016.